Success at Annual eHV Innovation Event
Tel Aviv, 14.11.2022

It was a pleasure hosting our partners and friends from abroad and Israel last week as part of the MIXiii Health-Tech.IL conference. We started off with a big partner meeting and networking event at the Maccabi Health care Services offices in Tel Aviv, where CEO Talor Sax presented updates on the strategy and activities of eHealth Ventures and Keren Shechter Azulay discussed the critical role of innovation within the Israeli healthcare system.

Later, six portfolio companies: Agamon, YonaLink, EfA Technologies, Olive Diagnostics, Nervio, and AccuLine - had the opportunity to update our partners on their recent commercial and scientific achievements.

The following day we held our annual Innovation Event. Out of 55 companies who applied, 5 finalists presented to the audience, our partners, and guests at the event. Congratulations to IdentifAI Genetics, Remepy, ToDx, NeuroHelp, and EyeContact on making it to the finals.

Many thanks to our partners who joined us in Tel Aviv and Jerusalem for making our events so special!

Thank you to Samantha Palmer and Gladys Nunez from Amgen Ventures, Kelly Krajnik and Shai Ran Sapir from Mayo Clinic Ventures, Yoav Bauman Ph.D and Matan Soll, PhD, MBA from Medison Pharma, Steve Shapiro & Suzi Shapiro, Guy Sharon and Daniel Aalsvel from Invista, Joseph Drebitko and Iva Drebitko, Yair Hadar and Amos Hadar from the A. Hadar Group, Ján Bocko and Marián Škorník from VGD, Jana Koysova from HENDI CENTRUM, and all our other friends who made the trip.

Looking forward to continuing our journey to success and seeing you all soon!

About eHealth Ventures:

The eHealth Ventures partnership is a leading investor in early-stage digital health companies. It includes 2 VC funds and a technological incubator with an exclusive focus on digital health and significant government non-dilutive funding. Partners include Maccabi (a leading Israeli HMO), Amgen (global biotech giant), the Mayo Clinic, Medison Ventures, Arad Investments, and the Hadar Group. The team has reviewed over 1,500 companies to date and invested in a portfolio of 17 highly innovative companies (digital diagnostics, therapeutics, home care and Bioconvergence).

For additional information contact: info@ehv.health

We move fast and push our companies to move faster.
Timing is everything - we get it.
For all news items
eHealth Ventures by Numbers:
Portfolio Companies
Companies Reviewed
Years of experience for 4 principles
Fair Value Appreciation on Portfolio
Partners & Collaborators